AT492288T - Polypeptide for wide protection against hypervirulent meningokokkin lines - Google Patents

Polypeptide for wide protection against hypervirulent meningokokkin lines

Info

Publication number
AT492288T
AT492288T AT03758486T AT03758486T AT492288T AT 492288 T AT492288 T AT 492288T AT 03758486 T AT03758486 T AT 03758486T AT 03758486 T AT03758486 T AT 03758486T AT 492288 T AT492288 T AT 492288T
Authority
AT
Austria
Prior art keywords
meningokokkin
polypeptide
lines
protection against
wide protection
Prior art date
Application number
AT03758486T
Other languages
German (de)
Inventor
Mariagrazia Pizza
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0223741A priority Critical patent/GB0223741D0/en
Priority to GB0305831A priority patent/GB0305831D0/en
Priority to GB0309115A priority patent/GB0309115D0/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Priority to PCT/IB2003/004848 priority patent/WO2004032958A1/en
Publication of AT492288T publication Critical patent/AT492288T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
AT03758486T 2002-10-11 2003-10-02 Polypeptide for wide protection against hypervirulent meningokokkin lines AT492288T (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0223741A GB0223741D0 (en) 2002-10-11 2002-10-11 Composition with five meningococcal antigens
GB0305831A GB0305831D0 (en) 2003-03-13 2003-03-13 Broad protection meningococcal vaccines
GB0309115A GB0309115D0 (en) 2003-04-22 2003-04-22 Broad protection meningococcal vaccines
PCT/IB2003/004848 WO2004032958A1 (en) 2002-10-11 2003-10-02 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages

Publications (1)

Publication Number Publication Date
AT492288T true AT492288T (en) 2011-01-15

Family

ID=32096623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758486T AT492288T (en) 2002-10-11 2003-10-02 Polypeptide for wide protection against hypervirulent meningokokkin lines

Country Status (20)

Country Link
US (2) US8663656B2 (en)
EP (3) EP2351579B1 (en)
JP (4) JP4697706B2 (en)
CN (1) CN1809380B (en)
AT (1) AT492288T (en)
AU (1) AU2003274511B2 (en)
BR (1) BR0315228A (en)
CA (1) CA2501812C (en)
CY (2) CY1111341T1 (en)
DE (1) DE60335477D1 (en)
DK (2) DK2351579T3 (en)
ES (1) ES2608048T3 (en)
HU (1) HUE031886T2 (en)
LU (1) LU92241I2 (en)
MX (1) MXPA05003863A (en)
NL (1) NL300604I2 (en)
NZ (1) NZ562998A (en)
PT (2) PT1549338E (en)
SI (2) SI2351579T1 (en)
WO (1) WO2004032958A1 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026021A1 (en) * 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
EP1645631B1 (en) 1998-05-01 2007-10-24 Novartis Vaccines and Diagnostics, Inc. Neisseria antigens and compositions
US20110033491A1 (en) * 1998-11-02 2011-02-10 Andrew Robinson Multicomponent meningococcal vaccine
EP1228217B1 (en) 1999-04-30 2012-11-21 Novartis Vaccines and Diagnostics S.r.l. Conserved neisserial antigens
WO2000071725A2 (en) * 1999-05-19 2000-11-30 Chiron S.P.A. Combination neisserial compositions
PT2275552E (en) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Neisserial antigenic peptides
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
BR0107679A (en) 2000-01-17 2004-07-06 Chiron Spa outer membrane vesicle vaccine (OMV) comprising outer membrane proteins from serogroup B Neisseria meningitidis
AU3948801A (en) 2000-02-28 2001-09-12 Chiron Spa Heterologous expression of neisserial proteins
KR20030024811A (en) * 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
WO2003010194A2 (en) * 2001-07-27 2003-02-06 Chiron Srl. Meningococcus adhesins nada, app and orf 40
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
EP2572707A3 (en) * 2002-02-20 2013-11-06 Novartis Vaccines and Diagnostics, Inc. Microparticles with adsorbed polypeptide-containing molecules
HUE029200T2 (en) * 2002-08-02 2017-03-28 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens
MXPA05003863A (en) 2002-10-11 2005-09-08 Chiron Srl Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages.
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
PT2172213E (en) 2003-01-30 2013-06-03 Novartis Ag Injectable vaccines against multiple meningococcal serogroups
AU2011224064A1 (en) * 2003-10-02 2011-10-06 Novartis Vaccines And Diagnostics S.R.L. Liquid vaccines for multiple meningococcal serogroups
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
AU2004277758A1 (en) 2003-10-02 2005-04-14 Novartis Vaccines And Diagnostics S.R.L. Liquid vaccines for multiple meningococcal serogroups
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
RU2379052C2 (en) 2004-04-30 2010-01-20 Чирон С.Р.Л. Meningococcal conjugate vaccination
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0413868D0 (en) 2004-06-21 2004-07-21 Chiron Srl Dimensional anlaysis of saccharide conjugates
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
GB0419846D0 (en) 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
EP2433647A3 (en) 2005-01-27 2012-06-06 Children's Hospital & Research Center at Oakland GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
ES2385045T3 (en) 2005-02-18 2012-07-17 Novartis Vaccines And Diagnostics, Inc. Urotogenic Escherichia coli immunogens
SG160329A1 (en) 2005-02-18 2010-04-29 Novartis Vaccines & Diagnostic Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
EA012528B1 (en) 2005-06-27 2009-10-30 Глаксосмитклайн Байолоджикалс С.А. Immunogenic composition
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
EP1962902A2 (en) * 2005-12-06 2008-09-03 Universita Degli Studi di Padova Methods and compositions relating to adhesins as adjuvants
EP2064230A2 (en) 2006-08-16 2009-06-03 Novartis AG Immunogens from uropathogenic escherichia coli
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp Polynucleotide vector that comprises recombinant cell comprising the vector polypeptide, antibody, composition comprising the polynucleotide, vector, polypeptide or antibody recombinant cell, using the composition and method for preparing the same composition and prepare a composi
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
CA2695467A1 (en) * 2007-08-02 2009-03-26 Children's Hospital & Research Center At Oakland Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
US20100285069A1 (en) 2007-10-19 2010-11-11 Mario Contorni Meningococcal vaccine formulations
EP2886551A3 (en) * 2008-02-21 2015-09-23 Novartis AG Meningococcal fhbp polypeptides
EP2268618B1 (en) 2008-03-03 2015-05-27 Novartis AG Compounds and compositions as tlr activity modulators
EP2294085A1 (en) * 2008-06-09 2011-03-16 Novartis AG Antibodies against neisserial factor h binding protein
IT1394288B1 (en) * 2008-09-12 2012-06-06 Novartis Vaccines & Diagnostic Immunogens of proteins that bind the h factor.
US8585505B2 (en) 2008-12-15 2013-11-19 Tetris Online, Inc. Inter-game interactive hybrid asynchronous computer game infrastructure
NZ593674A (en) 2008-12-17 2013-03-28 Novartis Ag Meningococcal vaccines including hemoglobin receptor
EP2411045A1 (en) 2009-03-24 2012-02-01 Novartis AG Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
NZ595234A (en) 2009-03-24 2013-12-20 Novartis Ag Adjuvanting meningococcal factor h binding protein
WO2010144734A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
EP2443250B8 (en) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
BR112012004275A2 (en) * 2009-08-27 2016-11-16 Novartis Ag hybrid polypeptides including meningococcal fhbp sequences
BR112012004276A2 (en) * 2009-08-27 2017-10-24 Novartis Ag ADJUVANT COMPRISING ALUMINUM, OLIGONUCLEOTIDE and POLYCATION
JO3257B1 (en) 2009-09-02 2018-09-16 Novartis Ag Compounds and compositions as tlr activity modulators
MX2012002723A (en) 2009-09-02 2012-04-11 Novartis Ag Immunogenic compositions including tlr activity modulators.
WO2011039631A2 (en) 2009-09-30 2011-04-07 Novartis Ag Expression of meningococcal fhbp polypeptides
WO2011051893A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
BR112012014624A8 (en) 2009-12-15 2017-12-26 Novartis Ag homogeneous suspension of immunopotentiation compounds and uses of these
US20130071422A1 (en) 2010-03-18 2013-03-21 Michele Pallaoro Adjuvanted vaccines for serogroup b meningococcus
WO2011119759A1 (en) 2010-03-23 2011-09-29 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
US9827300B2 (en) 2010-03-30 2017-11-28 Children's Hospital & Research Center Oakland Factor H binding proteins (FHBP) with altered properties and methods of use thereof
US10478483B2 (en) 2010-06-25 2019-11-19 Glaxosmithkline Biologicals Sa Combinations of meningococcal factor H binding proteins
TWI503411B (en) * 2010-08-11 2015-10-11 Nat Health Research Institutes Preparation and purification of subunit vaccine for neisseria meningitidis (nm) group b isolates
KR101594228B1 (en) 2010-08-23 2016-02-15 와이어쓰 엘엘씨 STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
EP2719395A1 (en) 2010-09-01 2014-04-16 Novartis AG Adsorption of immunopotentiators to insoluble metal salts
WO2012031271A1 (en) 2010-09-04 2012-03-08 Novartis Ag Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
GB201015132D0 (en) * 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
CA2810971A1 (en) * 2010-09-10 2012-03-15 Novartis Ag Developments in meningococcal outer membrane vesicles
ES2585328T3 (en) 2010-09-10 2016-10-05 Wyeth Llc Non-lipidated variants of ORF2086 antigens from Neisseria meningitidis
PL2822947T3 (en) 2012-03-07 2017-01-31 Glaxosmithkline Biologicals Sa Arginine salts of a tlr7 agonist
CA2866406A1 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
US10196429B2 (en) 2012-03-09 2019-02-05 Pfizer Inc. Neisseria meningitidis composition and methods thereof
PE20190458A1 (en) 2012-03-09 2019-04-01 Pfizer Neisseria meningitidis compositions and methods thereof
WO2013186753A1 (en) 2012-06-14 2013-12-19 Novartis Ag Vaccines for serogroup x meningococcus
EP2877492A1 (en) 2012-07-27 2015-06-03 Institut National de la Sante et de la Recherche Medicale (INSERM) Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
WO2014037472A1 (en) 2012-09-06 2014-03-13 Novartis Ag Combination vaccines with serogroup b meningococcus and d/t/p
EP3400960A1 (en) 2012-09-18 2018-11-14 GlaxoSmithKline Biologicals S.A. Outer membrane vesicles
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
CA2918547A1 (en) 2013-08-02 2015-02-05 Peter T. Beernink Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof
RU2662968C2 (en) 2013-09-08 2018-07-31 Пфайзер Инк. Immunogenic composition for neisseria meningitidis (options)
WO2016014719A1 (en) * 2014-07-23 2016-01-28 Children's Hospital & Research Center Oakland Factor h binding protein variants and methods of use thereof
WO2016184860A1 (en) * 2015-05-18 2016-11-24 Universita' Degli Studi Di Trento Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
KR20190112081A (en) 2017-01-31 2019-10-02 화이자 인코포레이티드 Neisseria meningitidis composition and method thereof

Family Cites Families (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4239746A (en) * 1973-06-30 1980-12-16 Dezso Istvan Bartos Complement fixation test employing reactants in a disposable package
US4239749A (en) 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
SE8205892D0 (en) 1982-10-18 1982-10-18 Bror Morein Immunogenic membrane protein complex, seen for the front up and tell priority over derav as immune stimulant and as vaccine
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US5916588A (en) 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US20020146764A1 (en) * 1985-03-28 2002-10-10 Chiron Corporation Expression using fused genes providing for protein product
IT1187753B (en) 1985-07-05 1987-12-23 Sclavo Spa Glycoprotein conjugate to attivita 'trivalent immunogenic
DE3622221A1 (en) * 1986-07-02 1988-01-14 Max Planck Gesellschaft A method for the recombinant production of proteins using Gram-negative host cells
EP0273116A3 (en) 1986-10-09 1990-05-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Gonococcal and meningococcal polypeptides, vaccines and diagnostics
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
NL8802046A (en) 1988-08-18 1990-03-16 Gen Electric A polymer mixture with polyester, and paraffin sulfonate, articles formed therefrom.
AU631377B2 (en) 1988-08-25 1992-11-26 Liposome Company, Inc., The Affinity associated vaccine
DE3841091A1 (en) 1988-12-07 1990-06-13 Behringwerke Ag Synthetic antigenic, process for their production and their use
DE68921895T3 (en) 1988-12-19 2003-05-22 American Cyanamid Co Meningococcales class I outer membrane protein vaccine.
NL8803111A (en) 1988-12-19 1990-07-16 Nederlanden Staat Multivalent meningococcal Class I outer membrane protein vaccine.
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
DE68907045D1 (en) 1989-01-17 1993-07-15 Eniricerche Spa Synthetic peptides and their use as a general carrier for the preparation of immunogenic conjugates that are suitable for the development of synthetic vaccines.
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
AU651949B2 (en) 1989-07-14 1994-08-11 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
IT1237764B (en) 1989-11-10 1993-06-17 Eniricerche Spa Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use for the development of synthetic vaccines.
SE466259B (en) 1990-05-31 1992-01-20 Arne Forsgren Protein D - an IgD-binding protein FROM Haemophilus influenzae, and anvaendning this Foer analysis, vaccines and uppreningsaendamaal
EP0467714A1 (en) 1990-07-19 1992-01-22 Merck & Co., Inc. The class II protein of the outer membrane of neisseria meningitidis
IL98715D0 (en) 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
CU22302A1 (en) * 1990-09-07 1995-01-31 Cigb Codifying nucleotidic sequence for a protein of the external membrane of neisseria meningitidis and the use of that protein in preparing vaccines.
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
EP0575553B1 (en) 1991-03-14 1998-12-16 Imclone Systems, Inc. Recombinant hybrid porin epitopes
IT1262896B (en) 1992-03-06 1996-07-22 Compounds conjugates formed by heat shock proteins (hsp) poly- and oligo-saccharides, their use for the production of vaccines.
FR2692592B1 (en) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc DNA fragments coding for the subunits of the transferrin receptor from Neisseria meningitidis and methods expressing them.
DK0671948T3 (en) 1992-06-25 1997-09-01 Smithkline Beecham Biolog A vaccine composition containing adjuvants
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
NL9201716A (en) 1992-10-02 1994-05-02 Nederlanden Staat Buitenmembraanvesikel which is provided with a group of polypeptides which have at least the immune function of membrane-bound outer membrane proteins (OMPs), process for their preparation, as well as a vaccine comprising such a buitenmembraanvesikel.
DK0812593T4 (en) 1993-03-23 2008-05-13 Smithkline Beecham Biolog Vaccine preparations containing 3-O-deacylated monophosphoryl lipid-A
DE69423383D1 (en) 1993-05-13 2000-04-20 American Cyanamid Co Preparation and uses of LOS-depleted outer membrane proteins of Gram-negative cocci
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
ES2210262T3 (en) 1993-09-22 2004-07-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Procedure for activating a soluble glucido with the help of new cianilantes reagents to produce immunogenic structures.
GB9326174D0 (en) 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
FR2720408B1 (en) 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments of Neisseria meningitidis Tbp2.
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur Proteinase k resistant surface protein of neisseria meningitidis
US6287574B1 (en) * 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
CA2217178C (en) 1995-04-25 2009-09-29 Smithkline Beecham Biologicals S.A. Vaccines containing a saponin and a sterol
FR2734484B1 (en) 1995-05-24 1997-06-27 Pasteur Merieux Serums Vacc liquid vaccine composition and method of manufacture
NZ311000A (en) 1995-06-07 1999-04-29 Smithkline Beecham Biolog Vaccine comprising a polysaccharide antigen-carrier protein conjugate and a free carrier protein
DK0833662T4 (en) 1995-06-23 2011-02-28 Smithkline Beecham Biolog Vaccine composition comprising a Haemophilus influenza B polysaccharide conjugate antigen adsorbed on aluminum phosphate
GB9513261D0 (en) 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
AT261313T (en) * 1995-09-18 2004-03-15 Us Army Medical Res Materiel C Improved methods subunits proteasome for production of non-covalently complexed and multivalent vaccines against
FR2739624B1 (en) 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc New subunit of Neisseria meningitidis tbp2
EP0877816A1 (en) 1996-02-01 1998-11-18 North American Vaccine, Inc. Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines
FR2751000B1 (en) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Specific DNA of bacteria of the species Neisseria meningitidis, obtaining their processes and their biological applications
US6472518B1 (en) 1996-10-24 2002-10-29 Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services Invasion associated genes from Neisseria meningitidis serogroup B
WO1998040100A1 (en) 1997-03-10 1998-09-17 Ottawa Civic Loeb Research Institute USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
GB9712347D0 (en) 1997-06-14 1997-08-13 Smithkline Beecham Biolog Vaccine
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
ES2201551T3 (en) 1997-09-05 2004-03-16 Glaxosmithkline Biologicals S.A. Oil in water emulsions containing saponins.
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
AU9363798A (en) 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ES2333071T5 (en) * 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Neisseria meningitidis antigens
EP0978565B1 (en) 1998-01-30 2007-10-10 Asubio Pharma Co., Ltd. Process for producing peptide with the use of accessory peptide
AU759391B2 (en) 1998-02-12 2003-04-10 Wyeth Holdings Corporation Pneumococcal and meningococcal vaccines formulated with interleukin-12
US7018637B2 (en) 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
US6303114B1 (en) 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens
HU0101619A3 (en) 1998-04-09 2003-11-28 Smithkline Beecham Biolog Adjuvant compositions
GB9808866D0 (en) 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP1645631B1 (en) * 1998-05-01 2007-10-24 Novartis Vaccines and Diagnostics, Inc. Neisseria antigens and compositions
US20070026021A1 (en) * 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
GB9810276D0 (en) 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6248329B1 (en) 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US6562798B1 (en) 1998-06-05 2003-05-13 Dynavax Technologies Corp. Immunostimulatory oligonucleotides with modified bases and methods of use thereof
GB9817052D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Biolog Vaccine
GB9818004D0 (en) 1998-08-18 1998-10-14 Smithkline Beecham Biolog Novel compounds
HU0103100A3 (en) 1998-08-19 2005-11-28 Baxter Healthcare Sa Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
WO2000022430A2 (en) 1998-10-09 2000-04-20 Chiron Corporation Neisseria genomic sequences and methods of their use
EP1605061A1 (en) * 1999-04-30 2005-12-14 Chiron Corporation Neisseria genomic sequences and methods of their use
AU750587B2 (en) 1998-10-16 2002-07-25 Smithkline Beecham Biologicals (Sa) Adjuvant systems and vaccines
US6610306B2 (en) * 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
EP1123403A1 (en) 1998-10-22 2001-08-16 The University Of Montana OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF
GB9823978D0 (en) 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US20030215469A1 (en) * 1998-11-02 2003-11-20 Microbiological Research Authority Multicomponent meningococcal vaccine
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
ES2228454T3 (en) 1999-02-26 2005-04-16 Chiron S.R.L. Improvement of the bacterial activity of neisseria antigens with oligonucleotides containing motives cg.
EP1034792A1 (en) 1999-03-11 2000-09-13 Ingileif Jonsdottir Intranasal delivery of pneumococcal polysaccharide vaccines
EP1880735A3 (en) 1999-03-19 2008-03-12 GlaxoSmithKline Biologicals S.A. Vaccine
FR2791895B1 (en) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Use of trehalose to stabilize a liquid vaccine
CA2365914A1 (en) 1999-04-09 2000-10-19 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
EP1228217B1 (en) 1999-04-30 2012-11-21 Novartis Vaccines and Diagnostics S.r.l. Conserved neisserial antigens
WO2000071725A2 (en) * 1999-05-19 2000-11-30 Chiron S.P.A. Combination neisserial compositions
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
CZ20021043A3 (en) 1999-09-24 2002-08-14 Smithkline Beecham Biologicals S. A. Use of polyoxyethylene sorbitan ester in combination with an octoxynol for preparing an auxiliary agent
AU766635B2 (en) 1999-09-24 2003-10-23 Smithkline Beecham Biologicals (Sa) Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
GB9925559D0 (en) 1999-10-28 1999-12-29 Smithkline Beecham Biolog Novel method
PT2275552E (en) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Neisserial antigenic peptides
JP4840956B2 (en) * 1999-11-29 2011-12-21 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 85kDa Neisseria antigen
BR0107679A (en) * 2000-01-17 2004-07-06 Chiron Spa outer membrane vesicle vaccine (OMV) comprising outer membrane proteins from serogroup B Neisseria meningitidis
AU3108001A (en) 2000-01-20 2001-12-24 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for inducing a th2 immune response
AU2818101A (en) 2000-01-25 2001-08-07 University Of Queensland, The proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
AU3948801A (en) * 2000-02-28 2001-09-12 Chiron Spa Heterologous expression of neisserial proteins
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
EA006313B1 (en) 2000-06-29 2005-10-27 Глаксосмитклайн Байолоджикалс С.А. Multi-valent immunogenic compositions and methods for using same
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP2292632A3 (en) 2000-09-26 2012-07-25 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
GB0108024D0 (en) * 2001-03-30 2001-05-23 Chiron Spa Bacterial toxins
US7838015B2 (en) * 2001-10-03 2010-11-23 Novartis Vaccines And Diagnostics, Inc. Adjuvanted meningococcus compositions
AU2002309706A1 (en) 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
WO2003009869A1 (en) 2001-07-26 2003-02-06 Chiron Srl. Vaccines comprising aluminium adjuvants and histidine
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
WO2003010194A2 (en) * 2001-07-27 2003-02-06 Chiron Srl. Meningococcus adhesins nada, app and orf 40
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2335979T3 (en) 2001-09-14 2010-04-07 Cytos Biotechnology Ag Immunostimulator cpg packaging in virus similar particles: preparation method and its use.
JP4360906B2 (en) 2001-09-14 2009-11-11 サイトス バイオテクノロジー アーゲー In vivo activation of antigen-presenting cells to enhance the immune response induced by virus-like particles
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
WO2003035836A2 (en) 2001-10-24 2003-05-01 Hybridon Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
NZ535968A (en) 2002-03-26 2006-08-31 Chiron S Modified saccharides having improved stability in water
HUE029200T2 (en) * 2002-08-02 2017-03-28 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens
US7785608B2 (en) * 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
MXPA05003863A (en) 2002-10-11 2005-09-08 Chiron Srl Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages.
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
PT2172213E (en) 2003-01-30 2013-06-03 Novartis Ag Injectable vaccines against multiple meningococcal serogroups
GB0315021D0 (en) * 2003-06-26 2003-07-30 Chiron Srl Immunogenic gonococcal compositions
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
AU2004277758A1 (en) 2003-10-02 2005-04-14 Novartis Vaccines And Diagnostics S.R.L. Liquid vaccines for multiple meningococcal serogroups
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
GB0410866D0 (en) * 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
CA2656474A1 (en) * 2006-06-29 2008-01-03 Novartis Ag Polypeptides from neisseria meningitidis
EP2886551A3 (en) 2008-02-21 2015-09-23 Novartis AG Meningococcal fhbp polypeptides
GB0819633D0 (en) 2008-10-25 2008-12-03 Isis Innovation Composition

Also Published As

Publication number Publication date
CA2501812A1 (en) 2004-04-22
EP1549338B1 (en) 2010-12-22
PT2351579T (en) 2016-12-22
BR0315228A (en) 2006-04-11
EP2353608A1 (en) 2011-08-10
JP5705450B2 (en) 2015-04-22
JP2013006868A (en) 2013-01-10
DK2351579T3 (en) 2017-01-09
JP2010215628A (en) 2010-09-30
CN1809380A (en) 2006-07-26
AU2003274511B2 (en) 2009-06-04
EP2351579A1 (en) 2011-08-03
US20140212449A1 (en) 2014-07-31
EP1549338A1 (en) 2005-07-06
DK1549338T3 (en) 2011-03-28
US8663656B2 (en) 2014-03-04
CY1118606T1 (en) 2017-07-12
HUE031886T2 (en) 2017-08-28
PT1549338E (en) 2011-02-23
JP4697706B2 (en) 2011-06-08
CN1809380B (en) 2010-05-12
CY1111341T1 (en) 2015-08-05
US20060171957A1 (en) 2006-08-03
EP2351579B1 (en) 2016-09-21
JP2014218515A (en) 2014-11-20
LU92241I2 (en) 2013-09-04
DE60335477D1 (en) 2011-02-03
NL300604I2 (en) 2016-09-22
NZ562998A (en) 2008-05-30
MXPA05003863A (en) 2005-09-08
JP2006512402A (en) 2006-04-13
AU2003274511A1 (en) 2004-05-04
ES2608048T3 (en) 2017-04-05
SI2351579T1 (en) 2017-05-31
SI1549338T1 (en) 2011-04-29
CA2501812C (en) 2012-07-10
WO2004032958A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
DE60323498D1 (en) Tastverhältnisschätzer
DE60321836D1 (en) Gewebeablationsgerät
DE60320217D1 (en) Aussenfixateur
DE60307726D1 (en) Verweilkatheteranordnung
DE60314126D1 (en) Organowasserstoffsiliziumverbindungen
DE60315698D1 (en) fussgelenkorthose
DE60325068D1 (en) Zentrierkatheter
DE60325250D1 (en) Spleisskassettenaufbewahrungssystem
DE60307995D1 (en) Atemschutzmaskennachsteller
DE60303749D1 (en) humerusschulterprothese
DE60318740D1 (en) bisarylsulfonamides
DE60325993D1 (en) glyphlets
DE50309539D1 (en) Anti-hautalterungskosmetikum
DE60219360D1 (en) Bikonvexe festimmersionslinse
DE50305852D1 (en) Einspritzventil
DE60323110D1 (en) pfangsvorrichtung
DE60327940D1 (en) Listen-talk set
DE60331027D1 (en) appropriate system
DE50308210D1 (en) Zentrifugalölabscheider
DE60315877D1 (en) Fliessensäge
DE50306589D1 (en) Wischblatt
DE60305833D1 (en) Faraday TORCH
DE60329919D1 (en) En on tensidbasis
DE60322188D1 (en) Zytokin (zcytor17-ligand)
DE60323116D1 (en) nwortvorverarbeitung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549338

Country of ref document: EP